SL
CNMD icon

Salomon & Ludwin’s CONMED CNMD Stock Holding History

Salomon & Ludwin’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Buy
73
+32
+78% +$1.15K ﹤0.01% 1949
2026
Q1 		$1.43K Buy
41
+30
+273% +$1.22K ﹤0.01% 1975
2025
Q4 		$461 Sell
11
-131
-92% -$5.7K ﹤0.01% 2092
2025
Q3 		$6.83K Buy
+142
New +$7.36K ﹤0.01% 1577

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Salomon & Ludwin's CNMD Position: Q2 2026 in Review

Salomon & Ludwin increased its CONMED (CNMD) stake by 78% in Q2 2026, buying an estimated $1.15K and bringing the position to 73 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

Salomon & Ludwin first reported a position in CNMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.83K in Q3 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Salomon & Ludwin held 73 shares of CONMED worth $2.39K as of Q2 2026.
  • Salomon & Ludwin bought 32 CONMED shares in Q2 2026, an estimated $1.15K.
  • CONMED made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1949 holding.
  • Salomon & Ludwin first reported a position in CONMED in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's CONMED position peaked at $6.83K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.